Oxytocin inhibits ethanol consumption and ethanol‐induced dopamine release in the nucleus accumbens
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Alcohol (EtOH) is one of the most widely abused recreational drugs and is arguably the most harmful. However, current treatment options for alcohol‐use disorders generally have limited efficacy and poor uptake in the community. In this context, the neuropeptide oxytocin (OXT) has emerged as a promising potential treatment option for a number of substance‐use disorders, including alcoholism. The utility of OXT in reducing consumption of and craving for a wide range of substances may lie in its ability to modulate drug‐induced neurochemical effects within the mesolimbic dopamine pathway. However, the impact of OXT on EtOH actions in this pathway has yet to be explored. Here, we reveal that an acute intracerebroventricular (icv) infusion of OXT (1 µg/5 µl) attenuated voluntary EtOH (20 percent) self‐administration after chronic intermittent access to EtOH for 59 days (28 drinking sessions) in male Wistar rats. Next, we demonstrated that an acute intraperitoneal (ip) injection of EtOH (1.5 g/kg, 15 percent w/v) increased dopamine release within the nucleus accumbens in both EtOH‐naive rats and rats that had received 10 daily ip injections of EtOH. Icv OXT completely blocked the EtOH‐induced dopamine release in both EtOH‐naive and chronically treated rats. The attenuation of EtOH‐induced dopamine release by OXT may help to explain the reduced EtOH self‐administration observed following icv OXT infusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · cited 1×
“There is growing interest in the emerging utility of the neuropeptide oxytocin (OXT) as a novel treatment for numerous psychiatric disorders (Meyer-Lindenberg et al. 2011; Neumann & Landgraf 2012) including addiction (Buisman-Pijlman et al. 2013; McGregor & Bowen *These authors contributed equally.”
BackgroundAddiction: Beyond dopamine reward circuitry
Volkow, N. D., Wang, G.-J., Fowler, J. S., Tomasi, D., & Telang, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010654108 · Cited by 959
Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice
Neumann, I. D., Maloumby, R., Beiderbeck, D. I., Lukas, M., & Landgraf, R. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.003 · Cited by 511 · cited 8×
“As described previously (Neumann et al. 2013), 2 days after surgery, the microdialysis probe was perfused (3.”
BackgroundMethodInfluentialSelf-citationWallace, D. L., Han, M.-H., Graham, D. L., Green, T. A., Vialou, V., Iñiguez, S. D., Cao, J.-L., Kirk, A., Chakravarty, S., Kumar, A., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2257 · Cited by 342
Dopaminergic-neuropeptide interactions in the social brain
Skuse, D. H., & Gallagher, L. (2009) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2008.09.007 · Cited by 340
Breaking the loop: Oxytocin as a potential treatment for drug addiction
McGregor, I. S., & Bowen, M. T. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.12.001 · Cited by 268
Self-citationIntranasal oxytocin blocks alcohol withdrawal in human subjects
Pedersen, C. A., Smedley, K. L., Leserman, J., Jarskog, L. F., Rau, S. W., Kampov‐Polevoi, A., Casey, R. L., Fender, T., & Garbutt, J. C. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01958.x · Cited by 196
Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats
Slattery, D. A., & Neumann, I. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.038 · Cited by 195
Self-citationOxytocin and addiction: a review
L. Kovács, G., Sarnyai, Z., & Szabó, G. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00064-x · Cited by 195 · cited 3×
“In particular, OXT administration has now been shown to reduce the consumption of heroin, cocaine, METH and EtOH (Bentzley et al. 2014; Bowen et al. 2011; Carson et al. 2010; Kovacs et al. 1998; Peters et al. 2013; Qi et al. 2008; Qi et al. 2009).”
BackgroundWILLIAMS, J. R., CARTER, C. S., & INSEL, T. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb34393.x · Cited by 147 · cited 2×
“2009) with centrally administered OXT facilitating monogamous pair bond formation in prairie voles (Williams et al. 1992).”
BackgroundBowen, M. T., Carson, D. S., Spiro, A., Arnold, J. C., & McGregor, I. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027237 · Cited by 143 · cited 3×
“Perhaps most pertinent to the present study, peripherally administered OXT has been shown to cause both an acute and lasting reduction in EtOH self-administration in rodents (Bowen et al. 2011; Peters et al. 2013).”
BackgroundSelf-citationQi, J., Yang, J.-Y., Song, M., Li, Y., Wang, F., & Wu, C.-F. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0245-8 · Cited by 129
A brief history of oxytocin and its role in modulating psychostimulant effects
Carson, D. S., Guastella, A. J., Taylor, E. R., & McGregor, I. S. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881112473788 · Cited by 105
Self-citationThe role of oxytocin-dopamine interactions in cocaine-induced locomotor hyperactivity
Kovàcs, G. L., Sarnyai, Z., Babarczi, E., Szabó, G., & Telegdy, G. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90095-9 · Cited by 101
Young, K. A., Liu, Y., Gobrogge, K. L., Wang, H., & Wang, Z. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4275-13.2014 · Cited by 99
Succu, S., Sanna, F., Argiolas, A., & Melis, M. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.026 · Cited by 35 · cited 2×
“Within the NAc, OXT was shown to directly interact with reward circuitry during sexual activity (Succu et al. 2011) and social bonding (Ross et al.”
BackgroundHicks, C., Ramos, L., Reekie, T. A., Narlawar, R., Kassiou, M., & McGregor, I. S. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3902-5 · Cited by 23 · cited 1×
“More recently, peripheral OXT administration has been shown to reduce methamphetamine (METH)-conditioned place preference, METH self-administration and METH-induced hyperactivity in rats (Carson et al. 2010; Hicks et al. 2015; Qi et al. 2009).”
Background
Cited by
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999
Self-citationNeuroscience of Addiction: Relevance to Prevention and Treatment
Volkow, N. D., & Boyle, M. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17101174 · Cited by 322
Influence of stress associated with chronic alcohol exposure on drinking
Becker, H. C. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.028 · Cited by 191
Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques
Lee, M. R., Shnitko, T. A., Blue, S. W., Kaucher, A. V., Winchell, A. J., Erikson, D. W., Grant, K. A., & Leggio, L. (2020) · Nature Communications · doi:10.1038/s41467-020-15942-1 · Cited by 132
Oxytocin reduces alcohol cue-reactivity in alcohol-dependent rats and humans
Hansson, A. C., Koopmann, A., Uhrig, S., Bühler, S., Domi, E., Kiessling, E., Ciccocioppo, R., Froemke, R. C., Grinevich, V., Kiefer, F., et al. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.257 · Cited by 109
Metadata
- Authors
- Peters, S. T., Bowen, M. T., Bohrer, K., McGregor, I. S., & Neumann, I. D.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2016-01-25
- Volume
- 22
- Issue
- 3
- Pages
- 702-711
- ISSN
- 1355-6215 (ISSN-L)
- 1369-1600
- OpenAlex
- W2256358091
- Cited by
- 99
- References
- 17
- FWCI
- 20.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.